Moderate physical activity can help protect the nerve cells and thus foster healthy ageing, research from the University of ...

Privately-held Dewpoint Therapeutics, a Boston, USA, biotech developing therapeutics by targeting biomolecular condensates, ...

Mitsubishi Tanabe Pharma is offering Dewpoint Therapeutics up to $480 million biobucks in a new research pact centering ...

It is a dialogue-less heartfelt story about amyotrophic lateral sclerosis (ALS) disease, adapted from a character created by ...

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel ...

The results of CardinALS showed utreloxastat failed to meet its main and secondary goals, including several disease-related ...

Both companies will collaborate to advance a small molecule condensate modulator targeting TDP-43, with the potential to ...